Investigating other immunological markers such as IL-10, tumor necrosis factor-α, T-regulatory cells, or IgA secretion represents a promising area for future research for better characterization of the immunomodulatory mechanisms by which probiotics could influence glycemic control in diabetes. The gene discussed is IL10; the disease is diabetes mellitus.